Mucormycosis following COVID19: clinical case and literature review

Abstract

Mucormycosis is one of the most aggressive invasive mycoses. The mortality rate of patients with mucormycosis, depending on clinical form and background disease, varies from 30% to 100%. This article provides the first description of mucormycosis in Russia after infection caused by SARS-CoV-2, as well as a review of literature reports on mucormycosis in patients with COVID-19 (as of September 2021).

Keywords

• mucormycosis
• invasive fungal infection
• rhino-orbital mucormycosis
• zygomycosis
• covid-19
• rhizopus spp
• sars-cov-2